Page last updated: 2024-12-07

1,2-dilauroylphosphatidic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,2-Dilauroylphosphatidic acid (DLiPA)

**1,2-Dilauroylphosphatidic acid (DLiPA)** is a synthetic phospholipid. It is a diacylglycerol derivative, meaning it consists of a glycerol backbone with two fatty acid chains attached. In this case, the fatty acid chains are lauric acid, a saturated fatty acid with 12 carbon atoms.

**Why is it important for research?**

DLiPA is a valuable tool in research for several reasons:

* **Mimics natural signaling molecules:** It is a structural analogue of phosphatidic acid (PA), a key signaling molecule involved in a wide range of cellular processes. PA plays crucial roles in cell growth, proliferation, differentiation, membrane trafficking, and signal transduction pathways.
* **Acts as a potent activator:** DLiPA can effectively activate various cellular receptors and signaling pathways. It is known to activate:
* **Protein kinase C (PKC):** DLiPA can directly activate PKC, an important enzyme involved in cell signaling and diverse cellular functions.
* **Other intracellular signaling pathways:** DLiPA can also trigger other signaling cascades, including those involving phospholipase C, diacylglycerol kinase, and phosphoinositide 3-kinase.
* **Provides insights into cellular processes:** By studying the effects of DLiPA on cells, researchers can gain valuable insights into the roles of PA and related signaling pathways. This helps to understand how cells respond to stimuli, regulate their functions, and maintain homeostasis.
* **Potential therapeutic applications:** DLiPA's ability to activate specific signaling pathways makes it a potential therapeutic agent for various conditions. For example, it could be used to stimulate cell growth and repair in wound healing or to modulate immune responses.

**Specific research areas where DLiPA is utilized:**

* **Cell signaling and signal transduction:** Understanding the mechanisms by which DLiPA activates different signaling pathways.
* **Membrane trafficking and vesicle formation:** Investigating the role of PA and DLiPA in regulating membrane dynamics.
* **Cancer research:** Studying the effects of DLiPA on cancer cell growth, proliferation, and metastasis.
* **Immunology:** Exploring the potential of DLiPA as an immunomodulator.
* **Drug development:** Developing new therapeutic agents based on DLiPA's ability to activate specific signaling pathways.

**Overall, 1,2-dilauroylphosphatidic acid is a valuable research tool for studying various cellular processes, including signal transduction, membrane trafficking, and cell growth. Its ability to activate key signaling pathways makes it a potential therapeutic agent for diverse conditions.**

1,2-dilauroylphosphatidic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133279
MeSH IDM0124475

Synonyms (7)

Synonym
einecs 279-274-0
1-((phosphonooxy)methyl)ethylene dilaurate
1,2-dilauroylphosphatidic acid
13-[(phosphonooxy)methyl]hexacosanedioic acid
79806-85-2
1-[(phosphonooxy)methyl]ethylene dilaurate
DTXSID301000749
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]